Geneos Wealth Management’s Celanese CE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $48.6K | Sell |
1,056
-125
| -11% | -$7.24K | ﹤0.01% | 1471 |
|
|
2026
Q1 | $77.7K | Hold |
1,181
| – | – | ﹤0.01% | 1257 |
|
|
2025
Q4 | $49.9K | Buy |
+1,181
| New | +$48.2K | ﹤0.01% | 1397 |
|
|
2025
Q3 | – | Sell |
-513
| Closed | -$28.4K | – | 2604 |
|
|
2025
Q2 | $28.4K | Buy |
513
+270
| +111% | +$13.5K | ﹤0.01% | 1862 |
|
|
2025
Q1 | $13.8K | Sell |
243
-89
| -27% | -$5.56K | ﹤0.01% | 2114 |
|
|
2024
Q4 | $23K | Buy |
332
+4
| +1% | +$384 | ﹤0.01% | 1667 |
|
|
2024
Q3 | $44.6K | Buy |
328
+97
| +42% | +$12.8K | ﹤0.01% | 1239 |
|
|
2024
Q2 | $31.2K | Hold |
231
| – | – | ﹤0.01% | 1224 |
|
|
2024
Q1 | $39.7K | Hold |
231
| – | – | ﹤0.01% | 1147 |
|
|
2023
Q4 | $35.9K | Buy |
231
+6
| +3% | +$783 | ﹤0.01% | 1169 |
|
|
2023
Q3 | $28.2K | Hold |
225
| – | – | ﹤0.01% | 1259 |
|
|
2023
Q2 | $26.1K | Hold |
225
| – | – | ﹤0.01% | 1281 |
|
|
2023
Q1 | $24.5K | Hold |
225
| – | – | ﹤0.01% | 1279 |
|
|
2022
Q4 | $23K | Hold |
225
| – | – | ﹤0.01% | 1294 |
|
|
2022
Q3 | $20K | Hold |
225
| – | – | ﹤0.01% | 1316 |
|
|
2022
Q2 | $26K | Hold |
225
| – | – | ﹤0.01% | 1558 |
|
|
2022
Q1 | $32K | Hold |
225
| – | – | ﹤0.01% | 1569 |
|
|
2021
Q4 | $37K | Hold |
225
| – | – | ﹤0.01% | 1615 |
|
|
2021
Q3 | $34K | Hold |
225
| – | – | ﹤0.01% | 1665 |
|
|
2021
Q2 | $34K | Sell |
225
-869
| -79% | -$138K | ﹤0.01% | 1648 |
|
|
2021
Q1 | $171K | Buy |
1,094
+81
| +8% | +$11.1K | ﹤0.01% | 1044 |
|
|
2020
Q4 | $43K | Buy |
1,013
+731
| +259% | +$90.9K | ﹤0.01% | 1530 |
|
|
2020
Q3 | $29K | Hold |
282
| – | – | ﹤0.01% | 1477 |
|
|
2020
Q2 | $23K | Sell |
282
-46
| -14% | -$3.83K | ﹤0.01% | 1555 |
|
|
2020
Q1 | $23K | Sell |
328
-40
| -11% | -$3.96K | ﹤0.01% | 1443 |
|
|
2019
Q4 | $45K | Hold |
368
| – | – | ﹤0.01% | 1311 |
|
|
2019
Q3 | $44K | Hold |
368
| – | – | ﹤0.01% | 1244 |
|
|
2019
Q2 | $39K | Hold |
368
| – | – | ﹤0.01% | 1313 |
|
|
2019
Q1 | $36K | Sell |
368
-136
| -27% | -$13.4K | ﹤0.01% | 1295 |
|
|
2018
Q4 | $45K | Hold |
504
| – | – | ﹤0.01% | 1140 |
|
|
2018
Q3 | $57K | Hold |
504
| – | – | ﹤0.01% | 1109 |
|
|
2018
Q2 | $55K | Hold |
504
| – | – | ﹤0.01% | 994 |
|
|
2018
Q1 | $50K | Hold |
504
| – | – | ﹤0.01% | 993 |
|
|
2017
Q4 | $53K | Buy |
504
+40
| +9% | +$4.25K | ﹤0.01% | 973 |
|
|
2017
Q3 | $48K | Hold |
464
| – | – | ﹤0.01% | 964 |
|
|
2017
Q2 | $44K | Buy |
464
+136
| +41% | +$12.1K | ﹤0.01% | 970 |
|
|
2017
Q1 | $29K | Sell |
328
-15
| -4% | -$1.31K | ﹤0.01% | 1096 |
|
|
2016
Q4 | $27K | Hold |
343
| – | – | ﹤0.01% | 1059 |
|
|
2016
Q3 | $22K | Buy |
343
+18
| +6% | +$1.18K | ﹤0.01% | 1094 |
|
|
2016
Q2 | $21K | Buy |
325
+60
| +23% | +$4.17K | ﹤0.01% | 1096 |
|
|
2016
Q1 | $17K | Buy |
+265
| New | +$16.4K | ﹤0.01% | 1133 |
|
Other funds holding CE
Geneos Wealth Management's CE Position: Q2 2026 in Review
Geneos Wealth Management reduced its Celanese (CE) stake by 11% in Q2 2026, selling an estimated $7.24K and leaving 1,056 shares worth $48.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1471.
Geneos Wealth Management first reported a position in CE in Q1 2016 and has held it in 41 quarters since. The position peaked at $171K in Q1 2021. 460 funds tracked by Wall St. Rank hold CE as of Q2 2026.
- Geneos Wealth Management held 1,056 shares of Celanese worth $48.6K as of Q2 2026.
- Geneos Wealth Management sold 125 Celanese shares in Q2 2026, an estimated $7.24K.
- Celanese made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1471 holding.
- Geneos Wealth Management first reported a position in Celanese in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Celanese position peaked at $171K in Q1 2021.
- 460 funds tracked by Wall St. Rank held Celanese as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.